SREBF2 — Sterol Regulatory Element Binding Transcription Factor 2

SREBF2 — Sterol Regulatory Element Binding Transcription Factor 2

Overview

Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

SREBF2 — Sterol Regulatory Element Binding Transcription Factor 2

Overview

Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

Introduction

Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@carter2007]

The SREBF2 gene encodes sterol regulatory element binding factor 2 (SREBP-2), a transcription factor that regulates cholesterol homeostasis. SREBP-2 activates genes involved in cholesterol uptake and biosynthesis, including HMGCR and LDLR. Dysregulated SREBP-2 signaling has been implicated in Alzheimer's disease through effects on cholesterol metabolism, [amyloid precursor protein](/entities/app-protein) processing, and neuronal viability.

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SREBF2</th></tr>
<tr><td><b>Full Name</b></td><td>Sterol Regulatory Element Binding Transcription Factor 2</td></tr>
<tr><td><b>Chromosome</b></td><td>22</td></tr>
<tr><td><b>Location</b></td><td>22q13.31</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[6721](https://www.ncbi.nlm.nih.gov/gene/6721)</td></tr>
<tr><td><b>OMIM</b></td><td>[184757](https://www.omim.org/entry/184757)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000198911](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000198911)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q13568](https://www.uniprot.org/uniprotkb/Q13568/entry)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">253 edges</a></td>
</tr>
</table>
</div>

Function

SREBF2 plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms:

Role in Cholesterol Homeostasis

• Regulates cholesterol biosynthesis and uptake
• Maintains neuronal membrane composition
• Influences synaptic function and plasticity
• Modulates amyloid precursor protein (APP) processing

Brain Cholesterol Metabolism

The brain contains approximately 25% of the body's cholesterol but is isolated from peripheral cholesterol by the [blood-brain barrier](/entities/blood-brain-barrier). Key mechanisms include:

• Local cholesterol synthesis in [neurons](/entities/neurons) and glia
• CYP46A1-mediated 24-hydroxylation for efflux
• [ApoE](/proteins/apoe)-mediated cholesterol transport
• LDLR-mediated uptake

Disease Associations

Alzheimer's Disease

| Mechanism | Effect |
|-----------|--------|
| Altered cholesterol metabolism | Increases [Aβ](/proteins/amyloid-beta) production |
| Dysregulated APP processing | Enhances amyloidogenesis |
| Impaired synaptic cholesterol | Defects in neurotransmission |
| Oxidative stress | Neuronal vulnerability |

Other Associated Conditions

| Disease | Relationship |
|---------|-------------|
| Hypercholesterolemia | Primary association |
| Alzheimer's Disease | Secondary complication |
| Metabolic Syndrome | Comorbidity |

Therapeutic Implications

Statins and AD

HMGCR inhibitors (statins) have been studied extensively in AD:

• Observational studies suggest reduced AD risk with statin use
• Clinical trials have shown mixed results
• Lipophilic statins may be more effective due to brain penetration

Future Directions

• CYP46A1 activation for enhanced cholesterol efflux
• SREBP-2 modulators
• LDLR-targeted therapies
• Combination approaches targeting multiple pathways

Expression

The SREBF2 gene shows distinct expression patterns:

• Brain: Primary expression in neurons and [astrocytes](/entities/astrocytes)
• Liver: High expression for systemic cholesterol regulation
• Peripheral tissues: Variable expression

See Also

• [Genes/Srebf2](/genes/srebf2) — This page

Overview

Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• Cholesterol Metabolism in AD
• APOE Gene - Apolipoprotein E
• Lipid Rafts and Neurodegeneration
• Amyloid Precursor Protein

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: ABCA1/LDLR/SREBF2

Pathway Diagram

The following diagram shows the key molecular relationships involving SREBF2 — Sterol Regulatory Element Binding Transcription Factor 2 discovered through SciDEX knowledge graph analysis: